Pharmacogenetics of modafinil after sleep loss: catechol-O-methyltransferase genotype modulates waking functions but not recovery sleep

Clinical Pharmacology and Therapeutics
Sereina BodenmannHans-Peter Landolt


Sleep loss impairs waking functions and is homeostatically compensated in recovery sleep. The mechanisms underlying the consequences of prolonged wakefulness are unknown. The stimulant modafinil may promote primarily dopaminergic neurotransmission. Catechol-O-methyltransferase (COMT) catalyzes the breakdown of cerebral dopamine. A functional Val158Met polymorphism reduces COMT activity, and Val/Val homozygous individuals presumably have lower dopaminergic signaling in the prefrontal cortex than do Met/Met homozygotes. We quantified the contribution of this polymorphism to the effects of sleep deprivation and modafinil on subjective state, cognitive performance, and recovery sleep in healthy volunteers. Two-time 100 mg modafinil potently improved vigor and well-being, and maintained baseline performance with respect to executive functioning and vigilant attention throughout sleep deprivation in Val/Val genotype subjects but was hardly effective in subjects with the Met/Met genotype. Neither modafinil nor the Val158Met polymorphism affected distinct markers of sleep homeostasis in recovery sleep. In conclusion, dopaminergic mechanisms contribute to impaired waking functions after sleep loss.


Mar 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·J A Horne
Jun 20, 1998·JAMA : the Journal of the American Medical Association·J M LyznickiM A Williams
Jul 10, 2001·Molecular Psychiatry·Y DauvilliersM Tafti
Nov 24, 2001·American Journal of Respiratory and Critical Care Medicine·A I PackJ K Matheson
Jan 18, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·K W RammohanH N Nagaraja
Nov 6, 2002·Psychopharmacology·Danielle C TurnerBarbara J Sahakian
Feb 4, 2003·Nature Reviews. Neuroscience·Jacqueline N Wood, Jordan Grafman
Feb 6, 2003·Journal of Biological Rhythms·Till RoennebergMartha Merrow
Apr 30, 2003·Proceedings of the National Academy of Sciences of the United States of America·Venkata S MattayDaniel R Weinberger
Jul 17, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Hans-Peter LandoltPeter Achermann
Oct 29, 2004·The New England Journal of Medicine·Steven W LockleyUNKNOWN Harvard Work Hours, Health and Safety Group
Mar 2, 2005·Journal of Clinical Psychopharmacology·Delia C RandallSandra E File
Mar 31, 2005·Seminars in Neurology·Jeffrey S Durmer, David F Dinges
May 17, 2005·Sleep Medicine Reviews·Isabelle Arnulf
Aug 5, 2005·The New England Journal of Medicine·Charles A CzeislerUNKNOWN U.S. Modafinil in Shift Work Sleep Disorder Study Group
Oct 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·J V RéteyH-P Landolt
Feb 16, 2006·Biological Psychiatry·Elizabeth M TunbridgeDaniel R Weinberger
Feb 24, 2006·Journal of Sleep Research·Julie M GottseligHans-Peter Landolt
Jul 18, 2006·Current Pharmaceutical Design·Nancy J Wesensten
Aug 4, 2006·The Journal of Pharmacology and Experimental Therapeutics·Bertha K MadrasAlan J Fischman
Dec 14, 2006·Sleep·Robert Joseph Thomas, Kenneth Kwong
Feb 13, 2007·Lancet·Yves DauvilliersEmmanuel Mignot
Mar 10, 2007·Current Biology : CB·Antoine U ViolaDerk-Jan Dijk
May 2, 2007·Sleep Medicine·Thien Thanh Dang-VuPierre Maquet
May 5, 2007·European Journal of Pharmacology·Marsha M DopheideDennis K Miller
Aug 23, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michael J Minzenberg, Cameron S Carter
Feb 16, 2008·Journal of Sleep Research·Eun Yeon JooSeung Bong Hong
Jun 14, 2008·Sleep·Eun Yeon JooSeung Bong Hong

❮ Previous
Next ❯


Apr 14, 2010·Psychopharmacology·Monica L AndersenLeonard L Howell
May 28, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Scott GradyCharles A Czeisler
Sep 11, 2009·Seminars in Neurology·Namni GoelDavid F Dinges
Jan 6, 2012·Journal of Clinical Psychopharmacology·Keith G HeinzerlingSteven J Shoptaw
Oct 19, 2011·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Namni Goel, David F Dinges
Oct 17, 2009·Industrial Health·Hans P A Van Dongen, Gregory Belenky
Nov 4, 2015·Annual Review of Pharmacology and Toxicology·Sebastian C HolstHans-Peter Landolt
Feb 4, 2014·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·J GilleenS Kapur
Mar 26, 2013·Current Opinion in Neurobiology·Mathias BasnerDavid F Dinges
Sep 19, 2009·NeuroImage·Michael W L CheeVitali Zagorodnov
Dec 4, 2014·Sleep Medicine Reviews·Yves DauvilliersHans Peter Landolt
Nov 27, 2010·Biological Psychiatry·Linda ScorielsPeter B Jones
Dec 7, 2013·Journal of Psychopharmacology·C TurnerA N Nicholson
Feb 24, 2018·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Amandine ValomonHans-Peter Landolt
Aug 29, 2009·Current Opinion in Pulmonary Medicine·Andrew C KingHans P A Van Dongen
Oct 27, 2010·Pharmacogenetics and Genomics·Anne Emilia Tammimäki, Pekka T Männistö
Jun 12, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Cameron H GoodVincent Mysliwiec
Sep 8, 2010·Sleep·Sereina Bodenmann, Hans-Peter Landolt
Sep 26, 2017·Current Neurology and Neuroscience Reports·Namni Goel

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.